Part 2/6:
In the United States, due to the complex supply chain and market practices, a single vial of insulin can cost around $300 or more. This high list price persists despite the low production costs, largely because three dominant pharmaceutical companies control roughly 90% of the global insulin market. These companies have a history of coordinating price increases, effectively keeping costs high for consumers and healthcare systems.